MEET THE TEAM
Executive Team
Mr. David Nitsan
CEO
Mr. Nitsan has over 15 years of experience as a global CEO, transforming companies into market leaders while driving profits and achieving growth targets. His background spans the medical device, technology, and high tech industries, directing start-ups from idea to commercialization, M&A (EXIT) through fundraising, tactical negotiation, and due diligence.
Mr. Joshua Hershcovich
CHAIRMAN AND FOUNDER
Mr. Hershcovich is the Chairman of the Board. He has vast hands-on experience in capital markets, mergers and acquisitions, and developing public companies from a financial and entrepreneurial perspective
Prof. James Shapiro
Dr. A. M. James Shapiro (born in Leeds, England) is a British-Canadian surgeon best known for leading the clinical team that developed the Edmonton Protocol – an islet transplant procedure for the treatment of type 1 diabetes. Dr. Shapiro is Professor of Surgery, Medicine, and Surgical Oncology at the University of Alberta[1] and the Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program with Alberta Health Services
Prof. Stefan Bornstein
Director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus of the Technical University of Dresden as well as the medical faculty’s vice dean of international affairs and development and a member of the supervisory board of the University Hospital of Dresden. He is also the chair and honorary consultant for diabetes and endocrinology at King’s College London.
Prof. Lonnie Shea
The University of Michigan. Lonnie D. Shea is a world-leading biomaterial scientist and co-inventor of the Cour nanoparticle technology platform. He currently serves as the Steven A. Goldstein Collegiate Professor in the Department of Biomedical Engineering at the University of Michigan.
Prof. James Shaw
Co-Director of the Newcastle University Translational and Clinical Research Institute, Regenerative Medicine, Stem Cells and Transplantation Theme. Also, Newcastle University Chief Investigator for the Northern Alliance Advanced Therapies Treatment Centre, one of three Innovate UK-funded centres with the goal of accelerating trials and clinical adoption of cell and gene therapies.
Prof. Arieh Warshel
NOBEL PRIZE WINNER
Nobel Prize winner in chemistry (2013) for the development of multiscale models for complex chemical systems. Professor Warshel is a pioneer in computational studies on functional properties of biological molecules. Distinguished Professor of Chemistry and Biochemistry at University of Southern California in Los Angeles, USA, also worked in other renowned research institutes, such as Weizmann Institute of Science, Israel and the Laboratory of Molecular Biology at Cambridge, England.
Prof. Eduardo Mitrani
INVENTOR OF BETALIN'S TECHNOLOGY
Professor of Developmental Biology at the Institute of Life Sciences at the Hebrew University of Jerusalem. Specializes in tissue engineering and adult tissue repair and regeneration.